Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BDSX | Stock Options (Right to buy) | Award | $0 | +5.62K | $0.00 | 5.62K | Feb 23, 2021 | Common Stock | 5.62K | $0.77 | Direct | F1, F2 | |
transaction | BDSX | Stock Options (Right to buy) | Award | $0 | +5.62K | +100% | $0.00 | 11.2K | Mar 10, 2022 | Common Stock | 5.62K | $0.77 | Direct | F1, F3 |
transaction | BDSX | Stock Options (Right to buy) | Award | $0 | +5.85K | $0.00 | 5.85K | Mar 10, 2022 | Common Stock | 5.85K | $2.29 | Direct |
Id | Content |
---|---|
F1 | On March 22, 2019, the Reporting Person was granted an option to purchase 16,845 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2019, 2020 and 2021 fiscal years. The performance criteria was not met for fiscal year 2019, resulting in the cancellation of 5,615 shares underlying the option. |
F2 | On February 23, 2021, the Compensation Committee of the Issuer's board of directors (the "Compensation Committee") confirmed the performance criteria were met for fiscal year 2020, resulting in the vesting of 5,615 shares underlying the option. |
F3 | On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 5,615 shares underlying the option. |